These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 11292702)

  • 1. Recombinant urease and urease DNA of Coccidioides immitis elicit an immunoprotective response against coccidioidomycosis in mice.
    Li K; Yu JJ; Hung CY; Lehmann PF; Cole GT
    Infect Immun; 2001 May; 69(5):2878-87. PubMed ID: 11292702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic vaccination against Coccidioides immitis: comparison of vaccine efficacy of recombinant antigen 2 and antigen 2 cDNA.
    Jiang C; Magee DM; Quitugua TN; Cox RA
    Infect Immun; 1999 Feb; 67(2):630-5. PubMed ID: 9916069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance to Coccidioides immitis in mice after immunization with recombinant protein or a DNA vaccine of a proline-rich antigen.
    Abuodeh RO; Shubitz LF; Siegel E; Snyder S; Peng T; Orsborn KI; Brummer E; Stevens DA; Galgiani JN
    Infect Immun; 1999 Jun; 67(6):2935-40. PubMed ID: 10338502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of signal sequence in vaccine-induced protection against experimental coccidioidomycosis.
    Jiang C; Magee DM; Ivey FD; Cox RA
    Infect Immun; 2002 Jul; 70(7):3539-45. PubMed ID: 12065493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coadministration of interleukin 12 expression vector with antigen 2 cDNA enhances induction of protective immunity against Coccidioides immitis.
    Jiang C; Magee DM; Cox RA
    Infect Immun; 1999 Nov; 67(11):5848-53. PubMed ID: 10531239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity of a 48-kilodalton recombinant T-cell-reactive protein of Coccidioides immitis.
    Kirkland TN; Thomas PW; Finley F; Cole GT
    Infect Immun; 1998 Feb; 66(2):424-31. PubMed ID: 9453590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the proline-rich antigen of Coccidioides immitis as a vaccine candidate in mice.
    Kirkland TN; Finley F; Orsborn KI; Galgiani JN
    Infect Immun; 1998 Aug; 66(8):3519-22. PubMed ID: 9673228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction and evaluation of a novel recombinant T cell epitope-based vaccine against Coccidioidomycosis.
    Hurtgen BJ; Hung CY; Ostroff GR; Levitz SM; Cole GT
    Infect Immun; 2012 Nov; 80(11):3960-74. PubMed ID: 22949556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of two homologous proline-rich proteins of Coccidioides posadasii as candidate vaccines against coccidioidomycosis.
    Herr RA; Hung CY; Cole GT
    Infect Immun; 2007 Dec; 75(12):5777-87. PubMed ID: 17875631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A recombinant aspartyl protease of Coccidioides posadasii induces protection against pulmonary coccidioidomycosis in mice.
    Tarcha EJ; Basrur V; Hung CY; Gardner MJ; Cole GT
    Infect Immun; 2006 Jan; 74(1):516-27. PubMed ID: 16369008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A recombinant beta-1,3-glucanosyltransferase homolog of Coccidioides posadasii protects mice against coccidioidomycosis.
    Delgado N; Xue J; Yu JJ; Hung CY; Cole GT
    Infect Immun; 2003 Jun; 71(6):3010-9. PubMed ID: 12761077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Both CD4+ and CD8+ T cells can mediate vaccine-induced protection against Coccidioides immitis infection in mice.
    Fierer J; Waters C; Walls L
    J Infect Dis; 2006 May; 193(9):1323-31. PubMed ID: 16586371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An agonist of human complement fragment C5a enhances vaccine immunity against Coccidioides infection.
    Hung CY; Hurtgen BJ; Bellecourt M; Sanderson SD; Morgan EL; Cole GT
    Vaccine; 2012 Jun; 30(31):4681-90. PubMed ID: 22575167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Th1-type immune response to a Coccidioides immitis antigen delivered by an attenuated strain of the non-invasive enteropathogen Vibrio cholerae.
    Silva AJ; Benitez JA
    FEMS Immunol Med Microbiol; 2005 Mar; 43(3):393-8. PubMed ID: 15708313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune response of vaccinated and non-vaccinated mice to Coccidioides posadasii infection.
    Xue J; Hung CY; Yu JJ; Cole GT
    Vaccine; 2005 May; 23(27):3535-44. PubMed ID: 15855012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A genetically engineered live attenuated vaccine of Coccidioides posadasii protects BALB/c mice against coccidioidomycosis.
    Xue J; Chen X; Selby D; Hung CY; Yu JJ; Cole GT
    Infect Immun; 2009 Aug; 77(8):3196-208. PubMed ID: 19487479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coccidioidomycosis: host response and vaccine development.
    Cox RA; Magee DM
    Clin Microbiol Rev; 2004 Oct; 17(4):804-39, table of contents. PubMed ID: 15489350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Localization within a proline-rich antigen (Ag2/PRA) of protective antigenicity against infection with Coccidioides immitis in mice.
    Peng T; Shubitz L; Simons J; Perrill R; Orsborn KI; Galgiani JN
    Infect Immun; 2002 Jul; 70(7):3330-5. PubMed ID: 12065470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rational Design of T Lymphocyte Epitope-Based Vaccines Against Coccidioides Infection.
    Hurtgen BJ; Hung CY
    Methods Mol Biol; 2017; 1625():45-64. PubMed ID: 28584982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection of mice against Coccidioides immitis intranasal infection by vaccination with recombinant antigen 2/PRA.
    Shubitz L; Peng T; Perrill R; Simons J; Orsborn K; Galgiani JN
    Infect Immun; 2002 Jun; 70(6):3287-9. PubMed ID: 12011027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.